We are live on ! Find out more
RG

Redmile Group Portfolio holdings

AUM $1.51B
1-Year Est. Return 164.17%
This Fund
S&P 500
This Quarter Est. Return
+15.5%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$2.94B
AUM Growth
+$354M
Cap. Flow
+$71.5M
Cap. Flow %
2.43%
Top 10 Hldgs %
43.94%
Holding
91
New
27
Increased
20
Reduced
25
Closed
12

Top Buys

1
CLVS
Clovis Oncology, Inc.
CLVS
+$85.5M
2
QURE icon
uniQure
QURE
+$52M
3
LH icon
Labcorp
LH
+$50.7M
4
XERS icon
Xeris Biopharma Holdings
XERS
+$46.9M
5
IFRX icon
InflaRx
IFRX
+$40.6M

Top Sells

1
AVXS
AveXis, Inc. Common Stock
AVXS
+$78.7M
2
PBYI icon
Puma Biotechnology
PBYI
+$74.6M
3
PEN icon
Penumbra
PEN
+$67.6M
4
ABT icon
Abbott
ABT
+$39.2M
5
RGNX icon
Regenxbio
RGNX
+$27.2M

Sector Composition

1 Healthcare 93.19%
2 Financials 1.03%
3 Technology 0%
4 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGRY icon
51
Surgery Partners
SGRY
$2.18B
$9.26M 0.31%
+621,300
New +$10.4M
STIM icon
52
Neuronetics
STIM
$124M
$7.98M 0.27%
+300,000
New +$8.16M
LUMO
53
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$7.67M 0.26%
179,083
-49,161
-22% -$2.25M
IMUX icon
54
Immunic
IMUX
$205M
$7.5M 0.25%
+2,738
New +$6.33M
INSP icon
55
Inspire Medical Systems
INSP
$1.49B
$7.13M 0.24%
+200,000
New +$6.46M
ONC
56
BeOne Medicines Ltd
ONC
$32.9B
$6.2M 0.21%
40,300
+300
+0.8% +$53.5K
CTMX icon
57
CytomX Therapeutics
CTMX
$799M
$6M 0.2%
262,400
-72,280
-22% -$1.85M
NVTA
58
DELISTED
Invitae Corporation
NVTA
$5.97M 0.2%
812,240
-1,327,280
-62% -$8.82M
SENS icon
59
Senseonics Holdings Inc
SENS
$268M
$5.42M 0.18%
+65,896
New +$4.72M
SRPT icon
60
Sarepta Therapeutics
SRPT
$1.82B
$4.11M 0.14%
+31,100
New +$2.93M
EIDX
61
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$3.88M 0.13%
+191,000
New +$4M
UBX
62
DELISTED
Unity Biotechnology
UBX
$3.77M 0.13%
+25,040
New +$3.66M
ACRS icon
63
Aclaris Therapeutics
ACRS
$749M
$2.13M 0.07%
106,820
– –
VCEL icon
64
Vericel Corp
VCEL
$2.44B
$1.75M 0.06%
+180,873
New +$2.25M
ATYR
65
aTyr Pharma
ATYR
$50.6M
$1.72M 0.06%
134,642
– –
OVID icon
66
Ovid Therapeutics
OVID
$457M
$951K 0.03%
121,950
-38,768
-24% -$333K
HZNP
67
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$427K 0.01%
25,800
+5,800
+29% +$88.4K
IHF icon
68
iShares US Healthcare Providers ETF
IHF
$1.19B
$367K 0.01%
10,435
– –
MYOK
69
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$356K 0.01%
+7,170
New +$347K
FLXN
70
DELISTED
Flexion Therapeutics, Inc.
FLXN
$343K 0.01%
13,260
+3,330
+34% +$86.4K
SAGE
71
DELISTED
Sage Therapeutics
SAGE
$340K 0.01%
+2,170
New +$341K
JAZZ icon
72
Jazz Pharmaceuticals
JAZZ
$15.2B
$274K 0.01%
+1,590
New +$260K
NVRO
73
DELISTED
NEVRO CORP.
NVRO
$271K 0.01%
+3,400
New +$282K
AMED
74
DELISTED
Amedisys
AMED
$233K 0.01%
+2,725
New +$200K
BHC icon
75
Bausch Health
BHC
$1.84B
$208K 0.01%
+8,930
New +$185K
1 2
3
4

Similar funds

ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
KP
Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return
HCMG
Howard Capital Management Group Los Angeles, California $1.51B AUM 21.57% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.51B AUM 25.86% 1-Year Est. Return
FCM
Fairholme Capital Management South Miami, Florida $1.51B AUM 28.27% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.52B AUM 18.08% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return